Porphyrin photosensitizers in photodynamic therapy and its applications

Jiayuan Kou; Dou Dou; Liming Yang

doi:10.18632/oncotarget.20189

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Porphyrin photosensitizers in photodynamic therapy and its applications

Jiayuan Kou, Dou Dou and Liming Yang _

PDF | HTML | How to cite

Oncotarget. 2017; 8:81591-81603. https://doi.org/10.18632/oncotarget.20189

Metrics: PDF 5265 views | HTML 10812 views | ?

Abstract

Jiayuan Kou1,2, Dou Dou3 and Liming Yang1

1Department of Pathophysiology, Harbin Medical University, Harbin, PR China

2Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, PR China

3Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, PR China

Correspondence to:

Liming Yang, email: [email protected]

Keywords: porphyrin photosensitizers, photodynamic therapy, tumor, application

Received: April 25, 2017 Accepted: July 29, 2017 Published: August 11, 2017

ABSTRACT

In 1841, the extraction of hematoporphyrin from dried blood by removing iron marked the birth of the photosensitizer. The last twenty years has witnessed extensive research in the application of photodynamic therapy (PDT) in tumor-bearing (or other diseases) animal models and patients. The period has seen development of photosensitizers from the first to the third generation, and their evolution from simple to more complex entities. This review focuses on porphyrin photosensitizers and their effect on tumors, mediated via several pathways involved in cell necrosis, apoptosis or autophagic cell death, and the preventive and therapeutic application of PDT against atherosclerosis.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20189

Publication Alerts

Post-Publication Promotion

Publication Discount

Reviews:

Porphyrin photosensitizers in photodynamic therapy and its applications

Abstract